US Patent 12,485,172 — assignment history and current owner

US 12,485,172 · Application 19/088,718

Pharmaceutical Products And Stable Liquid Compositions Of Il-17 Antibodies

Who owns US Patent 12,485,172?

US12485172 ("Pharmaceutical Products And Stable Liquid Compositions Of Il-17 Antibodies") — current assignee: NOVARTIS PHARMA AG. Status: Active, estimated expiration December 21, 2035. 3 recorded USPTO assignments.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 12,485,172 is NOVARTIS PHARMA AG. Based on the most recent ownership transfer record (recorded 2026-06-11).

Patent title
Pharmaceutical Products And Stable Liquid Compositions Of Il-17 Antibodies
Application number
19/088,718
Apparent operating assignee
NOVARTIS PHARMA AG
Patent status
Active, estimated expiration December 21, 2035
Recorded assignments
3

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Jun 26, 2015Sep 13, 2025Ownership TransferSERNO-SCHERSCH, KATHRINNOVARTIS PHARMA AG72891/943
Sep 23, 2015Sep 13, 2025Ownership TransferNOVARTIS PHARMA AGNOVARTIS AG72891/968
Dec 19, 2025Jun 11, 2026Ownership TransferNOVARTIS AGNOVARTIS PHARMA AG75712/291

Scrolls sideways on narrow screens

Chain of title

In 2025, SERNO-SCHERSCH, KATHRIN assigned the patent to NOVARTIS PHARMA AG. The most recent ownership transfer, recorded in 2026, lists NOVARTIS PHARMA AG as assignee.

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

Ownership settled? Give your AI the file.

Application 19/088,718 · US 12,485,172

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 12,485,172, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.